Ironwood Pharmaceuticals (IRWD) Accounts Payables (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Accounts Payables data on file, last reported at $3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 44.45% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (down 44.45% YoY), and the FY2025 full-year result was $2.9 million, up 36.25% from the prior year.
• Accounts Payables improved to $3.2 million in Q1 2026, from $2.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $7.8 million in Q4 2023 to a low of $118000.0 in Q1 2023.
• A 5-year average of $2.8 million and a median of $2.9 million in 2025 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables tumbled 77.82% in 2023 and surged 5172.88% in 2024, its largest moves.
• Tracing IRWD's Accounts Payables over 5 years: stood at $483000.0 in 2022, then surged by 1521.12% to $7.8 million in 2023, then slumped by 72.84% to $2.1 million in 2024, then jumped by 36.25% to $2.9 million in 2025, then gained by 11.7% to $3.2 million in 2026.
• Business Quant data shows IRWD's Accounts Payables at $3.2 million in Q1 2026, $2.9 million in Q4 2025, and $1.6 million in Q3 2025.